Medtronic (MDT) EBT Margin (2014 - 2026)

Medtronic has disclosed EBT Margin across 13 years of filings, most recently posting 15.57% for Q1 2026.

• EBT Margin for Q1 2026 came in at 15.57%, down 300.0% year-over-year; the trailing twelve-month figure through Jan 2026 was 15.68% (down 5.0% YoY), and the FY2025 annual result was 16.78%, up 184.0% from the prior year.
• EBT Margin came in at 15.57% for Q1 2026 at Medtronic, down from 17.82% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 20.47% in Q1 2022 to a low of 9.95% in Q2 2024.
• The 5-year median for EBT Margin is 17.79% (2023), against an average of 16.75%.
• Across the five-year window, EBT Margin soared 478 bps in 2022 and tumbled 820 bps in 2024, its largest moves.
• Medtronic's EBT Margin stood at 18.39% in 2022, then fell by 11 bps to 16.45% in 2023, then grew by 13 bps to 18.55% in 2024, then decreased by 4 bps to 17.82% in 2025, then fell by 13 bps to 15.57% in 2026.
• The last three EBT Margin figures came in at 15.57% (Q1 2026), 17.82% (Q4 2025), and 15.18% (Q3 2025), per Business Quant data.